The goal of this observational study is to investigate maternal serum Stathmin-1 levels in pregnancies affected by preeclampsia compared to healthy gestations. The main questions it aims to answer are: 1. What are the maternal serum Stathmin-1 levels in pregnancies with preeclampsia? 2. How do Stathmin-1 levels differ between preeclampsia with severe features and uncomplicated pregnancies? Researchers will compare Stathmin-1 levels in pregnancies with preeclampsia and preeclampsia with severe features to those in a control group of healthy pregnancies to assess differences in biomarker levels. Participants will undergo blood sample collection at 32-34 weeks of gestation. Have their blood samples processed for Stathmin-1 level measurement using ELISA.
Study Type
OBSERVATIONAL
Enrollment
80
Cam and Sakura City Hospital
Istanbul, Turkey (Türkiye)
Maternal Serum Stathmin-1 Levels
To identify and compare Maternal Serum Stathmin-1 Levels levels between the pre-eclampsia group, severe pre-eclampsia group, and the control group. This will help in understanding the biochemical environment associated with pre-eclampsia and its severity.
Time frame: Measured at the time of diagnosis and followed up until delivery.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.